Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Breast (Edinburgh, Scotland)|June 8, 2012
Intrahepatic and systemic therapy with oxaliplatin combined with capecitabine in patients with hepatic metastases from breast cancerD L Nielsen, H Nørgaard, L W Vestermark, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2012
Induction chemotherapy with capecitabine and oxaliplatin followed by chemoradiotherapy before total mesorectal excision in patients with locally advanced rectal cancerJ V Schou, F O Larsen, L Rasch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 21, 2010
Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancerC Frederiksen, C Qvortrup, I J Christensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2017
Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemo-radiotherapy before surgery in patients with locally advanced rectal cancerJ V Schou, F O Larsen, B S Sørensen, et al.
Acta Oncologica (Stockholm, Sweden)|October 4, 2021
Genomic landscape of treatment refractory metastatic colorectal cancerR L Eefsen, K S Simonsen, P Grundtvig, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2013
Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancerM K Boisen, J S Johansen, C Dehlendorff, et al.
Breast (Edinburgh, Scotland)|December 14, 2018
Hepatic arterial therapy with oxaliplatin and systemic capecitabine for patients with liver metastases from breast cancerS C Lindgaard, C M Brinch, B K Jensen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 22, 2018
Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancerA K Boysen, B S Sørensen, A C Lefevre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2024
Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 studyT André, K-K Shiu, T W Kim, et al.
Pageof 6